CJC-1295 NO DAC + Ipamorelin

CJC-1295 No DAC + Ipamorelin 10mg / 20mg Research Peptide

Product Overview

CJC-1295 No DAC + Ipamorelin combines two extensively studied growth hormone secretagogues commonly investigated in laboratory research involving growth hormone signaling, endocrine physiology, pituitary biology, IGF-1 regulation, peptide receptor interactions, and metabolic research. CJC-1295 No DAC is a short-acting Growth Hormone Releasing Hormone (GHRH) analog, while Ipamorelin is a highly selective Growth Hormone Secretagogue Receptor (GHSR-1a) agonist. Together, they provide researchers with a valuable model for studying complementary growth hormone signaling pathways under controlled laboratory conditions.

Northwest Peptides supplies CJC-1295 No DAC + Ipamorelin as a premium-quality lyophilized research peptide blend manufactured exclusively for laboratory research purposes. Every batch undergoes analytical verification and includes a batch-specific Certificate of Analysis (COA).

Available strengths:

• 10mg Total (5mg CJC-1295 No DAC + 5mg Ipamorelin)
• 20mg Total (10mg CJC-1295 No DAC + 10mg Ipamorelin)

Research Overview

Published laboratory research has investigated the complementary interaction between GHRH receptor stimulation and ghrelin receptor activation. Researchers continue evaluating this peptide combination in studies involving growth hormone pulsatility, pituitary physiology, endocrine regulation, IGF-1 biology, metabolic signaling, and peptide pharmacology.

Scientific literature continues expanding knowledge regarding synergistic endocrine signaling and growth hormone regulation through combined GHRH and GHS receptor activation.

Quick Facts

Quality Assurance

Every batch of CJC-1295 No DAC + Ipamorelin undergoes strict quality verification before release.

• ≥99% Purity Verified by HPLC
• Batch-Specific Certificate of Analysis (COA)
• Identity Verification
• Lyophilized for Long-Term Stability
• Sterile Laboratory Packaging
• Manufactured for Research Applications Only

Research Applications

Current published literature has investigated this peptide blend in:

• Growth hormone signaling
• GHRH receptor biology
• Ghrelin receptor biology
• Pituitary physiology
• IGF-1 regulation
• Endocrine signaling
• Hormone feedback mechanisms
• Metabolic physiology

Literature Summary

Scientific interest in CJC-1295 No DAC and Ipamorelin continues through peer-reviewed investigations examining pituitary biology, endocrine regulation, growth hormone secretion, peptide receptor interactions, and metabolic physiology. Ongoing laboratory research seeks to better understand the coordinated effects of GHRH and ghrelin receptor activation.

Related Research Peptides

Researchers investigating growth hormone biology frequently explore:

• CJC-1295 with DAC
• Ipamorelin
• Tesamorelin
• Hexarelin
• IGF-1 LR3
• GHRP-6 Acetate

Frequently Asked Questions

What is CJC-1295 No DAC + Ipamorelin?

A laboratory research peptide blend combining a short-acting GHRH analog with a selective ghrelin receptor agonist for studies involving growth hormone signaling.

Who may purchase this product?

Northwest Peptides supplies this peptide blend exclusively for lawful laboratory research.

What sizes are available?

• 10mg Total (5mg CJC-1295 No DAC + 5mg Ipamorelin)
• 20mg Total (10mg CJC-1295 No DAC + 10mg Ipamorelin)

Does every batch include a COA?

Yes.

How should it be stored?

Store lyophilized material at approximately -20°C.

How quickly are orders shipped?

Orders are typically processed within one business day.

References

Representative sources include peer-reviewed publications indexed by PubMed and scientific literature describing CJC-1295 No DAC, Ipamorelin, GHRH receptor biology, ghrelin receptor signaling, growth hormone physiology, and endocrine research.

Research Use Disclaimer

This product is intended strictly for lawful laboratory research purposes only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated by the U.S. Food and Drug Administration.

Call to Action

Order premium-quality CJC-1295 No DAC + Ipamorelin research peptide blend from Northwest Peptides. Every batch is independently COA verified and HPLC tested for laboratory research.